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Abstract  
Traditionally, free light chains (FLCs) are used as key serum biomarkers in the 
diagnosis and monitoring of plasma cell malignancies, but polyclonal FLCs can also 
be used as an accurate real-time indicator of immune-activation and inflammation.  
The primary aim of the present study was to assess the effects of exercise training 
status on serum FLCs in older adults, and secondly, to examine if training status 
moderated serum FLC responses to acute exercise.  Kappa and lambda serum 
FLCs levels were measured in 45 healthy older adults (aged ≥ 60 years) who were 
either sedentary, physically active or endurance trained.  FLCs were measured at 
baseline and in response to an acute bout of submaximal exercise.  The endurance 
trained group had significantly lower levels of kappa and lambda serum FLCs 
compared with physically active or sedentary elderly adults; these effects were 
independent of age, BMI and renal function.  There was no significant difference in 
whole immunoglobulins between groups.  Exercise training status had no effect on 
serum FLC responses to acute exercise, which were marginal.  In conclusion, 
endurance training was associated with lower FLC levels compared with less 
physically active individuals.  These findings suggest that long-term endurance 
training may be beneficial in reducing basal inflammation in older adults as well as 
elevated FLCs present in inflammatory and autoimmune conditions, often associated 
with ageing.  FLCs may serve as a useful biomarker for monitoring the efficacy of 
exercise intervention studies in healthy and clinical populations.   
 
Keywords: Free light chain, serum, immunoglobulin, exercise, inflammation, older 
adults 
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1. Introduction  
Light chains make up part of all antibodies (immunoglobulins), however, during 
plasma cell immunoglobulin synthesis kappa and lambda free light chains (FLCs) are 
produced in excess of intact immunoglobulin and released into the circulation (Suki 
and Massry, 1998).  Serum FLCs and the ratio of kappa:lambda light chains (Κ:λ 
ratio) have become key haematological biomarkers in the diagnosis, prognosis and 
monitoring of plasma cell malignancies (Davids et al., 2010; Dimopoulos et al., 2011; 
Dispenzieri et al., 2009; Pratt, 2008).  Additionally, free light chains have been shown 
to be intrinsically involved in immune and inflammatory processes (Braber et al., 
2012; Brebner and Stockley, 2013; Cohen et al., 2001; Hutchinson et al., 2012 ; 
Nakano et al., 2011; Redegeld et al., 2012).  Indeed, FLCs have been linked to a 
range of non-malignant inflammatory and autoimmune diseases.  Increases in 
polyclonal FLCs have been published in rheumatoid arthritis, multiple sclerosis, 
systemic lupus erythematosus, diabetes, and inflammatory bowel disease and may 
be useful in identifying and monitoring these conditions (Brebner and Stockley, 2013; 
Nakano et al., 2011; van der Heijden et al., 2006).  These studies suggest that 
polyclonal FLCs may serve as a broad marker of immune activation and 
inflammation.    
Ageing is accompanied by immune and neuroendocrine dysregulation and 
progression towards low-grade chronic inflammation (inflammaging), which are 
associated with chronic inflammatory and autoimmune diseases (Baylis et al., 2013; 
Franceschi and Campisi, 2014; Rehman and Masson, 2001; Weiskopf et al., 2009).  
Excess polyclonal FLC levels may be another feature of immunosenescence that 
occurs with age (Dispenzieri et al., 2012) and may serve as a marker of 
inflammaging.  However, excess FLC production may not be a feature of ageing per 
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se; similar ranges of serum FLCs have previously been observed between healthy 
young and elderly individuals (Heaney et al., 2016).  FLCs may be elevated due to 
immune activation and increased production or through reduced metabolism.  Due to 
their clearance through the kidneys, polyclonal FLCs rise with a decline in renal 
function, which is common in ageing individuals (Hutchinson et al., 2012 ; Weinstein 
and Anderson, 2010).   
Evidence suggests that exercise may be anti-inflammatory in elderly individuals.  
Higher levels of physical activity have been associated with lower levels of c-reactive 
protein (CRP) in individuals aged > 65 (Geffken et al., 2001).  Further, aerobic 
exercise training in older adults has been shown to reduced inflammatory markers, 
CRP, IL-6 and IL-8, compared to flexibility and strength training (Kohut et al., 2006).  
Studies showing lower pro-inflammatory mediators and improved immune function in 
trained older adults compared to untrained have been reviewed in detail elsewhere 
(Simpson et al., 2012).  To our knowledge the effect of exercise training on serum 
FLCs, in either older or young populations, has not yet been explored.  The positive 
benefits of exercise on anti-inflammaging may extend to this serological parameter.  
If so, FLCs could be a useful biomarker for monitoring the efficacy of exercise 
intervention studies in healthy and clinical populations.   
Recent studies have investigated the effect of acute exercise on serum FLCs.  
Kappa FLCs have been shown to be marginally elevated in runners following a 
marathon compared with pre-exercise levels, thought to be due to an acute and 
transient decline in renal function proportional to exercise intensity (Campbell et al., 
2016).  Although no changes in serum FLCs were seen in elderly individuals who 
undertook a 4-day walking exercise (Jacobs et al., 2014) the effect of training status 
– i.e., sedentary versus physical active – was not investigated. Training load has 
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previously been shown to influence baseline renal function (Touchberry et al., 2004) 
and thus may impact upon FLC clearance during acute exercise; to date, this has not 
been investigated in younger or older adults.  It is possible that individuals 
unaccustomed to exercise may be more vulnerable to transient perturbations in renal 
function, and consequently FLCs, with an acute bout of exercise.  The primary aim of 
the present study was to assess the effects of exercise training status on serum 
FLCs in older adults, and secondly, to examine if training status moderates serum 
FLC responses to acute exercise. 
 
2. Methods  
2.1. Participants  
Participants were community dwelling older adults (n = 45, 27 males) aged 67.25 ± 
5.06 years old from the UK.  Twenty percent of participants reported suffering from a 
chronic illness, which were hypertension and asthma, and 38% reported taking 
medication, such as anti-hypertensives, non-corticosteroid inhalers, statins and 
gastrointestinal medications.  Participants were excluded if suffering from any 
immune or endocrine disorder or any condition that precluded them from exercise, or 
if they had suffered from any acute illness in the two weeks prior to, or during the 
study.    
 
2.2. Exercise groups  
Participants were either sedentary (n = 13), physically active (n = 16), or endurance 
trained (n=16).  The sedentary participants were not currently involved in any regular 
exercise nor had they been for 5 years prior to the study; physically active 
participants regularly engaged in activities  that were of moderate intensity: rambling, 
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keep fit classes, swimming or badminton; the endurance trained older athletes were 
competitive runners, some of whom also cycled or took part in circuit training.  
Participants were given a 14 day exercise diary to assess how long each exercise 
group spent doing moderate and vigorous activities.  They were asked to record the 
type, duration and intensity of the activity.  The intensity was determined using a 0–
10 version of Rating of Perceived Exertion (RPE) scale (Borg, 1998), where 0 is rest 
and 10 was maximal effort.  Participants were briefed on the use of the RPE Scale 
and instructions and examples were also provided in the diary.  Time spent in 
moderate and vigorous activity was calculated based upon metabolic equivalents for 
specific activities (Ainsworth et al., 2000) and RPE (Nelson et al., 2007).  Minutes at 
each intensity level over the 14 day period were averaged per week.  
 
2.3. Exercise protocol 
Participants arrived to the laboratory between 08:00 and 09:00 where they were 
fitted with a HR monitor (Polar, Electro Kempele, Finland).  They were then 
familiarised with the procedure for collection of expired gas using Douglas bags.  
They then rested for 15 min before a blood sample was taken.  Participants then 
completed an acute bout of exercise in the form of an incremental submaximal 
treadmill test.  Participants began walking on the treadmill and speed was gradually 
increased until the participant reached a pace they considered ‘brisk walking’.  The 
gradient was increased every 4 min and during the final min of each stage expired 
gas samples were collected into Douglas bags (Cranlea, Birmingham, UK).  HR was 
monitored continuously throughout the exercise and the test was terminated once 
the participant had reached 75% of their predicted maximum HR, as determined by 
the formula: 208-(age×0.7) (Tanaka et al., 2001).  A blood sample was taken 
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immediately after exercise and 1 h post-exercise.  Between post- and 1 h post-
exercise participants were allowed to drink water ad libitum. VCO2 and VO2 were 
determined using O2/CO2 analyser (Servomex 1440, Crowborough, UK) and expired 
gas volumes were measured using a dry gas meter (Harvard Apparatus, 
Edenbridge, UK).  Using a regression equation created from plotting the relationship 
between HR and VO2 during the final three stages of exercise, VO2max was predicted. 
 
2.4. Blood samples and analyses  
Venous blood was collected from an antecubital vein into plain tubes (BD 
Vacutainer, Plymouth, UK) pre-, post- and 1 h post-exercise.  Blood was allowed to 
clot at room temperature before being centrifuged and the separated serum was 
stored at −20°C until analysis.  Serum kappa and lambda FLCs were quantified 
using a multi-plex bead-based assay using a Luminex platform (Bio-plex systems, 
BioRad Laboratories, California, USA).  This assay was developed by the Clinical 
Immunology Service at the University of Birmingham and uses mAbs specific for 
either kappa or lambda FLC (Abingdon Health Ltd, Oxford, UK) in a competitive 
inhibition format.  Full details for this assay have been described previously 
(Campbell et al., 2013).  Serum creatinine, CRP, IgG, IgA and IgM were measured 
on a Roche Hitachi Modular.  To minimize variation, all Roche Hitachi Modular 
analyses were performed on a single day using the same calibration set-up, batches, 
and user.  Plasma volume changes as a result of exercise were estimated between 
sample collection time points (Dill and Costill, 1974).   
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2.5. Free light chain parameters  
A range of FLC parameter outputs were analysed as part of this study.  In addition to 
concentrations of kappa and lambda FLC, the Κ:λ ratio and the difference between 
kappa and lambda FLC (FLC difference) were examined.  The Κ:λ ratio and FLC 
difference are classically used in conditions involving perturbed levels of FLC, such 
as plasma cell disorders (Dispenzieri et al., 2008; Siegel et al., 2009).  The sum of 
kappa and lambda FLCs (FLC sum) was also investigated as this measure has been 
employed in the general population who do not have clonal plasma cell disease 
(Dispenzieri et al., 2012).  All the above parameters were included to enable any 
future comparisons between healthy and clinical populations.  Participant’s serum 
FLC results were screened at baseline to exclude any patients with abnormal serum 
samples suggestive of undiagnosed monoclonal gammopathy of unknown 
significance (MGUS), immune stimulation or suppression or renal impairment.  The 
most widely cited reference ranges for FLCs are 3.30–19.40 mg/L for kappa, 5.7–
26.30 mg/L for lambda and 0.26–1.65 for the Κ:λ ratio (Katzmann et al., 2002).  The 
references ranges for the Luminex serum FLC used in this study were very similar: 
4.35–19.44 mg/L for kappa, 5.19–18.87 mg/L for lambda and 0.40–1.59 for the Κ:λ 
ratio (Campbell et al., 2013).  Serum FLC results at baseline were compared to both 
sets of reference ranges and anyone outside either of these ranges were excluded 
from the final analyses.  
 
2.6. Statistical analyses 
Analyses were undertaken using IBM SPSS version 21.  Renal function was 
assessed by calculating estimated creatinine clearance rates (eCrCl) and estimated 
glomerular filtration rate (eGFR) using the Cockcroft-Gault ([140-age] x mass x 
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constant [1.23 for men or 1.04 for women]/serum creatinine) and Modification of Diet 
in Renal Disease (186 x serum creatinine-1.154 x age -0.203 x 0.742 if female) formulas, 
respectively.  Univariate ANOVA was used to assess differences between exercise 
groups in: age, BMI, time spent in moderate/vigorous activity, VO2max and baseline 
renal function.  Chi-square was used to assess group differences in categorical 
variables: sex and chronic medication usage.  Repeated measures ANOVA was 
used to analyse responses to exercise, to test any main effects of exercise group 
and assess any group x time interactions for all serological variables:  FLC 
parameters (kappa and lambda concentrations, K:λ ratio, FLC difference, FLC sum), 
IgG, IgA, IgM, creatinine and CRP.  Percentage change in serological parameters 
were calculated between pre- and post-exercise time points and compared between 
exercise groups using univariate ANOVA.  When significant main effects of time or 
group were observed, Bonferroni post-hoc tests were applied.  Subsequent repeated 
measures/univariate ANCOVAs were performed for significant findings to control for 
any confounding effects of age and BMI in relation to effects of group, or plasma 
volume change in relation to effects of exercise.  Slight variations in degrees of 
freedom reflect occasional missing data or insufficient serum for analysis of all 
parameters.  Pearson’s correlation was used to examine the relationship between 
FLC parameters and immunoglobulins, CRP and creative at baseline and 
percentage change in response to exercise between FLCs and other serum 
parameters.  Greenhouse-Geisser corrected F values are reported for repeated 
measures analyses and partial η2, a measure of effect size, is reported throughout. 
3. Results   
3.1. Baseline serology screening                                                                                              
In order to exclude any individuals with abnormal serum samples, participant’s 
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serum FLC results were screened at baseline and compared to the normal reference 
ranges outlined in the Methods.  Four individuals exhibited abnormal Κ:λ ratios at 
baseline, and were consequently excluded from the study analyses.  Three of these 
individuals had elevated kappa or lambda FLCs, indicative of possible MGUS.  The 
other individual had very low levels of FLCs, suggestive of potential 
immunosuppression.  All other participants had kappa and lambda free light chain 
concentrations and Κ:λ ratios within the normal range.  Serology results at baseline 
for all final participants included in the study and their respective exercise group are 
shown in Table 1.  A total of 41 participants were included for all subsequent 
analyses: 11 sedentary, 16 physically active and 14 endurance trained individuals. 
Creatinine levels, eGrCl and eGFR (Table 1), indicators of renal function, did not 
significantly differ between exercise groups and therefore were not used as 
covariates for subsequent FLC analyses.   
 
3.2 Participants characteristics                                                                                      
Participant characteristics are displayed in Table 2.  Age (F(2,38) = 3.50, p = .040, η2 
= .156) and BMI (F(2,38) = 5.67, p = .007, η2 = .230) significantly differed between 
exercise groups; the endurance group was significantly younger compared with the 
physically active group, but not sedentary adults.  As anticipated, BMI was lower in 
endurance trained athletes compared with sedentary participants, although the 
endurance trained and physically active did not significantly differ in BMI.  The 
distribution of males and females between exercise groups did not significantly differ.  
As expected, exercise participation (exercise diary results) varied between groups.  
The physically active group engaged in a significantly higher amount of moderate 
activity per week compared with the other groups, F(2,34) = 22.14, p < .001, η2 = 
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.566.  The endurance trained group spent significantly more time participating in 
vigorous activity compared with the sedentary and physically active groups, F(2,34) 
= 30.37, p < .001, η2 = .641, and had a significantly higher VO2max compared with the 
other groups, F(2,32) = 24.26, p < .001, η2 = .603.  The distribution of individuals with 
chronic illness or taking chronic medication did not differ between exercise groups, 
nor was there any difference between FLC parameters based upon chronic illness or 
medication status; therefore these parameters were not included as covariates in 
subsequent analysis.   
 
3.3. Acute exercise parameters 
The mean exercise duration of the submaximal exercise bout was 23 min 24 sec ± 3 
min 18 sec and the final RPE obtained at the end of the exercise was 5.23 ± 1.05 
(“hard”).  The mean maximum heart rate achieved was 119.64 ± 40.80 bpm, 
equivalent to 76.50 ± 4.86 % predicted maximum HR.  There were no significant 
differences for any of these exercise parameters between the exercise groups. 
Overall, the mean ± SD plasma volume reduction post-exercise was -4.84 ± 5.12 % 
and by 1 h post-exercise had increased above pre-exercise levels by 3.45 ± 4.55%. 
Plasma volume increased by a mean of 8.80 ± 5.26 % between immediately post- 
and 1 h post-exercise, reflecting ad libitum drinking after the exercise.  There was no 
significant difference between training status groups for plasma volume changes.  
 
3.3. The effect of training status and acute exercise on free light chains  
Among the older adults, those who were endurance trained demonstrated 
significantly lower kappa (main effect of group: F(2,38) = 5.57, p = .008, η2 = .227) 
and lambda FLCs (main effect of group: F(2,38) = 8.63, p = .001, η2 = .312) in serum 
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compared with moderately trained and sedentary groups (Figure 1).  As kappa and 
lambda light chains were significantly lower in the endurance trained group, the FLC 
sum was also significantly lower; main effect of group, F(2,38) = 8.16, p = .001, η2 = 
.300.  Values for these parameters were lower at baseline and remained consistently 
lower across time points, with no group x time interactions in response to acute 
exercise.  There was a significant group x time interaction for the Κ:λ ratio, whereby 
endurance trained individuals had a significantly higher ratio pre-exercise compared 
to the other groups (F(4,76) = 8.09, p < .001, η2 = .299).  This was driven by higher 
kappa levels relative to lambda levels in the endurance trained group at this time 
point, illustrated by a significantly higher FLC difference pre-exercise, F(4,76) = 4.47, 
p = .003, η2 = .190.  These findings withstood adjustment for age and BMI.  
Descriptive statistics for FLC parameters between exercise groups at baseline are 
displayed in Table 1.  No sex differences were observed for any FLC parameters.  
Mean percentage changes for FLCs in response to exercise for the sample as a 
whole were small: mean ± SD kappa % change was 0.22 ± 7.75% and –0.36 ± 
7.29%; mean lambda % change was 1.18 ± 8.51% and –0.87 ± 9.26%, for pre- to 
post-exercise and pre- to 1 h post-exercise, respectively.  Although no significant 
group x time interactions were observed for mean FLC parameters in response to 
exercise, percentage changes did produce significant findings between groups.  As 
shown in Table 3, kappa FLCs significantly reduced between pre- to post-exercise in 
endurance trained athletes compared with the physically active group, F(2,38 = 3.80, 
p = .031, η2 = .167).  Alternatively, for lambda FLCs, endurance athletes 
demonstrated a significant percentage increase post-exercise compared to the 
sedentary group, F(2,38) = 4.25, p = .022, η2 = .183.  These group differences in 
percentage change were reduced to trends when controlling for either BMI (lambda, 
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p = .065) or age (kappa, p = .080).  As these findings were in response to exercise, 
plasma volume changes were also included as a potential confounding variable; the 
group difference in lambda remained significant (p = .040) although the kappa finding 
was reduced to a trend (p = .056).  No significant differences were observed 
between training groups for percentage change between pre- and 1 h post-exercise. 
 
3.4. The effect of exercise training status and acute exercise on immunoglobulin 
levels  
A significant main effect of time was observed for IgG, where values significantly 
increased post-exercise, followed by a significant decrease between post- and 1 h 
post-exercise,  F(2,74) = 26.79, p < .001, η2 = .420.  The same response pattern was 
observed for IgA and IgM, F(2,74) = 41.11, p < .001, η2 = .526 and F(2,74) = 23.21, 
p < .001, η2 = .386, respectively.  These significant changes in response to exercise 
are shown in Figure 2.  For IgG and IgA, these effects of time withstood adjustment 
for plasma volume change for pre- to post-exercise increases, but reductions 
between post- and 1h-post exercise were no longer significant;  IgM findings were no 
longer significant when adding plasma volume change as a covariate. No significant 
main effect of group or group x time interactions occurred for immunoglobulins.  
Immunoglobulins increased by similar proportion between pre- and post-exercise: 
4.85%, 5.42% and 4.79% for IgG, IgA and IgM, respectively.  The same consistency 
was observed across heavy chain subtypes for decreases between post- and 1 h 
post-exercise: –4.71% for IgG, –5.11% for IgA and –5.20% for IgM.  Percentage 
changes in immunoglobulins in response to exercise for the different exercise groups 
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are shown in Table 3.  No significant differences occurred in immunoglobulin 
percentage changes between exercise groups.  
3.5. The effect of exercise training status and acute exercise on creatinine levels and 
renal function  
As shown in Figure 3, creatinine  decreased from post- to 1h post-exercise, F(2,74) = 
4.66, p = .012, η2 = .112.  This decrease was equal to –3.67 ± 7.22% and levels at 1 
h were below pre-exercise values.  As a result of this reduction in creatinine, eGrCl 
(F(2,74) = 4.17, p = .019, η2 = .112) and eGFR (F(2,74) = 3.91, p = .024, η2 = .096) 
increased between these timepoints.  Upon controlling for plasma volume change 
between these time points, these main effects of time were no longer significant.  No 
effects of group or group x time interactions were observed.  Percentage changes in 
creatinine and renal function responses to exercise for the different exercise groups 
are shown in Table 3.  
 
3.6. The effect of exercise training status and acute exercise on CRP levels   
The sedentary group had higher CRP at baseline (Table 1), although this was not 
statistically significant.  A significant main effect of time occurred for CRP, F(2,74) = 
10.05, p < .001, η2 = .214 (Figure 3).  A significant increase in CRP was observed 
post-exercise by 6.11 ± 10.43%, followed by a decrease between post- and 1 h post-
exercise by –7.81± 7.21%, returning close to pre-exercise values.  The pre- to post-
exercise increase remained significant when controlling for plasma volume change, 
but the decrease post- to 1 h post-exercise did not withstand adjustment.  There 
were no group or group x time interactions for CRP, nor were there any difference in 
percentage change in CRP in response to exercise between groups (Table 3).  
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
 
15 
 
3.7. The relationship between free light chains and other serological parameters   
As expected, at baseline, kappa FLCs correlated significantly with IgG, r(38) = .480, 
p = 0.002, IgA, r(38) = .475, p = .002, and IgM , r(38) = .431, p = .005.  Similarly, 
lambda FLCs at baseline correlated with IgG, r(38) = .409, p = .002, IgA, r(38) = 
.467, p = .009, and IgM , r(38) = .359, p = .023.  No significant relationships existed 
between kappa or lambda FLC parameters with creatinine or CRP.  Percentage 
changes in response to exercise in kappa or lambda FL s did not correlate with 
percentage changes in immunoglobulins, creatinine or CRP.  
 
4. Discussion  
The present study demonstrates that endurance trained older adults have 
significantly lower levels of kappa and lambda serum FLCs compared with elderly 
adults who are physically active or sedentary.  These group differences in FLCs 
levels and consequently FLC sum were observed at baseline and throughout acute 
exercise, and were independent of age, BMI and renal function.  Further, these 
results are unlikely to be due to reverse causation, i.e. individuals with illness show 
elevated FLCs and are less able to exercise, given that participants were excluded if 
suffering from any immune or endocrine disorder or any condition that precluded 
them from exercise.  Due to the role of FLCs in immune and inflammatory 
processes, these findings suggest that long-term endurance training may reduce 
basal inflammation in older adults.   
Previous cross-sectional studies have shown that exercise trained older adults have 
lower levels of inflammatory markers and better immune function compared with less 
active/sedentary individuals (Geffken et al., 2001; Kohut and Senchina, 2004; 
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Simpson et al., 2012; Woods et al., 2012).  Evidence from intervention studies have 
also been reviewed, and, in general, aerobic exercise programmes of ≥ 6 months are 
able to reduce inflammatory markers and improve immune function in the elderly 
(Kohut and Senchina, 2004; Woods et al., 2012).  The present study extends the 
potential anti-inflammatory effects of exercise in older adults to FLCs.  It is also worth 
noting that CRP was lower in the physically active and endurance trained groups 
compared to those who were sedentary, although this difference was not significant.  
This could be a result of the modest sample size of this study or potentially FLCs 
could be a more sensitive marker than CRP in relation to exercise training.  As 
elevated polyclonal FLCs may be a characteristic of immunosenescence (Dispenzieri 
et al., 2012), the lower FLCs in the endurance trained individuals may be indicative 
of a slower rate of immune dysregulation and lower inflammatory profile with long-
term regular exercise.  It should be remembered that this is a relatively small initial 
study in this area of research and larger investigations should consider FLCs in 
conjunction with a range of immune parameters and other markers of inflammation.  
Additionally, intervention studies are required to establish if exercise (and what 
amount of exercise) can reduce FLCs in older adults presenting with elevated FLCs, 
in individuals suffering from inflammatory or autoimmune disease or haematological 
malignancies. 
The mechanism linking exercise and serum FLC levels is unknown.  By nature, the 
endurance trained participants in the present study had a lower BMI compared to the 
sedentary group, however, FLC differences withstood adjustment for BMI suggesting 
group diffrences were independent of potential inflammatory effects of adipose tissue 
in those less active.  There may be a direct effect of exercise on FLC levels through 
secretion rates and/or renal clearance, alternatively the relationship may best viewed 
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in context of other inflammatory and immune changes that take place with exercise.  
Importantly, there was no difference in whole immunoglobulin levels between 
exercise groups.  However, the higher levels of FLCs observed in sedentary and 
physically active groups do not appear to be due to impaired renal clearance, given 
that indicators of renal function  were comparable across groups.  It is possible that 
plasma cells are secreting the same amount of whole immunoglobulin, but lower 
amounts of FLC in the endurance-trained group.  Taken together, these suppositions 
need to be addressed in future studies to understand the mechanism of association 
between exercise and FLCs.   
Higher levels of polyclonal FLCs have previously been associated with survival.  
Dispenzeri et al (2012) demonstrated that individuals from the general population 
with the highest levels of FLCs were at greater risk of death.  The potential of serum 
FLCs as a predictive biomarker has also been shown in a hospital referral 
population; elevated FLCs were associated with an increased risk of mortality over 
4.5 years (Anandram et al., 2012).  However, it has yet to be established if the 
relationship between FLCs and disease and mortality is causative or a proxy marker 
for underlying diseases processes (Dispenzieri et al., 2012).  From this cross-
sectional study it cannot be determined if the lower levels of FLCs in endurance 
trained older adults may be protective against risk of adverse events.  Further, it 
should be noted that all participants in this study had FLC levels within the normal 
range and those who were endurance trained were engaging in what could be 
considered to be a high levels of vigorous exercise for this age group (on average 
nearly 4 hours per week).  Longitudinal studies with a larger number of participants 
will enable broader ranges of polyclonal FLC levels and training volumes to be 
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captured and are required to establish if exercise behaviour and FLCs interact to 
predict the risk of inflammatory disease or mortality.   
There were no significant overall effects of acute exercise on FLCs, with mean 
changes < ± 1.5% between time points.  This is consistent with prior investigations 
into acute exercise in both older adults (Jacobs et al., 2014) and young adults 
(Heaney et al., 2016) suggesting FLC production is generally not affected by 
exercise.  Conversely, marathon running has been shown to elicit modest elevations 
in Kappa FLCs proportional to exercise intensity (Campbell et al., 2016). Therefore 
exercise may have to be very intense and prolonged to induce changes in FLC 
levels.  Training status had marginal effects on percentage changes in FLCs in 
response to exercise, which emerged only as trends when controlling for 
confounding variables.  Consequently, the hypothesis that training status moderates 
FLC responses to acute exercise should be rejected.   
Serum immunoglobulins showed moderate correlations with FLC levels at baseline, 
although the training effect observed with FLCs was not replicated for IgG, IgA or 
IgM.  In addition, there were no differences in immunoglobulin responses to exercise 
between groups; these findings are consistent with previous reports (Nieman and 
Nehlsen-Cannarella, 1991).  Immunoglobulins significantly increased immediately 
post-exercise, in agreement with recent findings (Campbell et al., 2016).  Levels then 
decreased between post- and 1h post-exercise, reflecting increases in plasma 
volume due to rehydration through ad libitum water consumption during this time 
frame.  Interestingly, despite most likely having poorer renal function relative to 
younger adults, this type of graded submaximal exercise did not cause a spike in 
serum creatinine in this elderly cohort; an effect seen previously with more 
intense/prolonged exercise (McCullough et al., 2011).   
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4.1. Conclusions  
In this cross-sectional study of sedentary, physically active and endurance trained 
older adults aged ≥ 60 years, kappa and lambda serum FLC levels, and 
consequently the FLC sum, were found to be significantly lower in endurance trained 
individuals.  Acute exercise had negligible effects on FLCs and responses to 
exercise were not affected by training status.  This is the first time that FLCs have 
been examined in response to exercise habitual behaviour; these preliminary 
findings build upon previous evidence that exercise training may have an anti-
inflammatory effect in older adults.  Exercise may be able to attenuate not only 
inflammaging but may be beneficial in reducing FLC levels in inflammatory and 
autoimmune conditions associated with elevated polyclonal FLCs, which are 
prevalent in older populations.  This study  highlights the potential utility of FLCs as a 
biomarker in ageing and health research and suggests that FLCs may be useful in 
monitoring the efficacy of interventions aimed at reducing chronic inflammation, such 
as exercise.  
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Figure 1. Kappa (A) and lambda (B) free light chain (FLC) concentrations in serum in 
response to submaximal exercise in sedentary, moderately active and endurance trained 
older adults  
 Indicates a significant main effect of group: endurance trained older adults had lower 
overall kappa and lambda FLC concentrations in serum compared with sedentary and 
moderately trained groups, p < .05.  There were no significant effects of time or group x time 
interactions. Values are mean ± SEM 
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Figure 2. IgG, IgA and IgM concentrations in 
serum in response to submaximal exercise in 
older adults  
 Indicates a significant difference to pre 
exercise: IgG and IgA significantly increased 
pre-post exercise (p < .01).  
‡ IgM increased pre-post exercise but was no 
longer significant after controlling for plasma 
volume change (PV∆)  
† All immunoglobulins decreased between post-
and 1 h post exercise; these findings did not 
remain significant after controlling for PV∆, 
reflecting rehydration during this period   
Values are mean ± SEM  
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Figure 3. Creatinine (A) and c-reactive protein (CRP, B) concentrations in response to 
submaximal exercise in older adults.  Indicates a significant increase in CRP pre- to post-
exercise , p < 0.05;  † CRP and creatinine decreased between post- and 1h post-exercise 
but did not remain significant after controlling for changes in plasma volume, reflecting 
rehydration during this period. Values are mean ± SEM 
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Table 1.  Mean ± standard deviation baseline concentrations of serum free light chains, 
immunoglobulins, creatinine, estimated creatinine clearance rate (eCrCl), estimated 
glomerular filtration rate (eGFR) and c-reactive protein (CRP) in sedentary, physically active 
and endurance trained older adults  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Sedentary   Physically active  Endurance Trained  All participants  
Serum FLC concentration (mg/L)  
Kappa  12.13 ± 3.49 
 
12.39 ± 2.89 9.33 ± 2.66 11.26 ± 3.24 
Lambda  12.19 ± 3.51 12.93 ± 4.37 7.52 ± 1.89 10.88 ± 4.18 
Sum  24.32 ± 6.50 25.32 ± 6.89 16.85 ± 4.35 22.16 ± 7.05 
Difference  –.07 ± 2.58 
 
–.53 ± 2.72 1.81 ± 1.55 0.39 ± 2.51 
Ratio  1.01 ± 0.24 
 
1.014 ± 0.22 1.24 ± 0.24 1.09 ± 0.25 
Serum immunoglobulin concentration (g/L)  
IgG  8.87 ± 1.95 9.52 ± 2.25 8.83 ± 2.04 9.10 ± 2.07 
IgA  1.99 ± 0.96 2.34 ± 1.10 1.91 ± 0.66 2.09 ± 0.92 
IgM  0.86 ± 0.43 1.18 ± 0.52 0.89 ± 0.38 0.99 ± 0.47 
Creatinine (μmol/L) 91.00 ± 10.66 93.60 ± 12.70 93.92 ± 13.11 93.00 ± 12.08 
eCrCl (mL/min/1.73m2) 72.89 ± 23.59 65.99 ± 14.28  64.37 ± 12.31  67.25 ± 16.46 
eGFR (mL/min/1.73m2) 69.81 ± 14.29 68.05 ± 10.99  69.70 ± 9.05 69.13 ± 11.25 
 
CRP (mg/L) 
 
4.45 ± 8.26 1.45 ± 1.06 1.55 ± 1.61 2.31 ± 4.53 
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Table 2. Participant characteristics in sedentary, physically active and endurance 
trained older adults. Values are mean ± standard deviation. 
 
 
* significantly different to endurance trained, * p < .05, ** p < .01, *** p < .001 
†† significantly different to physically active, p < .01 
 
 
 
 
 
 
 
 
 
 
 
 
 Sedentary   Physically active  Endurance Trained  
Age  67.90 ± 5.19  69.31 ± 4.64* 64.64 ± 4.94 
BMI  26.62 ± 3.99** 25.46 ± 2.65 22.75 ± 2.43 
Chronic illness, n (%) 4 (36%) 3 (19%) 2 (14%) 
Chronic medication, n (%) 6 (55%) 6 (38%) 4 (29%) 
Males, n (%)  6 (54%) 11 (69%) 10 (71%)  
Moderate activity time per 
week (min) 
 
13.63 ± 31.07†† 277.88 ± 167.29 51.53 ± 61.68†† 
Vigorous activity time per 
week (min) 
 
0 ± 0*** 22.50 ± 50.60*** 233.27 ± 129.64 
VO2max (mL/kg/min) 32.87 ± 7.85*** 35.30 ± 6.65*** 50.99 ± 4.15 
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Table 3.  The effects of acute exercise on mean percentages changes in serum free light 
chains, immunoglobulins, creatinine and c-reactive protein (CRP) in sedentary, physically 
active and endurance trained older adults  
 Sedentary   Physically active  Endurance Trained  
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Serum FLC concentration  
Kappa     
% ∆ pre–post 0.68 3.33 –3.70* 
% ∆ pre–1 h post 1.15 0.67 –2.72  
Lambda    
% ∆ pre–post –3.20 0.21 5.70
†
 
% ∆ pre–1 h post –1.42 –4.02 3.15 
Serum immunoglobulin concentration  
IgG     
% ∆ pre–post 6.57 3.03 5.24 
% ∆ pre–1 h post 1.54 –1.10 –0.45  
IgA     
% ∆ pre–post 6.63 4.05 5.90 
% ∆ pre–1 h post 0.69 –0.29 –0.32 
IgM     
% ∆ pre–post 6.16 3.88 4.56 
% ∆ pre–1 h post –0.01 –1.30 –0.80 
Creatinine     
% ∆ pre–post 2.49 2.21 2.11 
% ∆ pre–1 h post –3.78 –2.07 –5.31 
eCrCl    
% ∆ pre–post –1.88 
 
–1.17 
 
–1.72 
 
% ∆ pre–1 h post 2.30 
 
1.41 
 
3.94 
 
eGFR    
% ∆ pre–post –3.86 
 
–1.19 
 
–1.97 
 
% ∆ pre–1 h post 0.81 
 
1.25 
 
4.60 
 
CRP     
% ∆ pre–post 9.53 4.89 4.58 
% ∆ pre–1 h post –0.30 –2.36 –4.12 
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* significantly different to physically active, p < .05                                                                              
† significantly different to sedentary, p < .05 
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Highlights  
 
 Endurance training was associated with lower levels of FLCs in older adults   
 Exercise training status did not influence FLC responses to acute exercise  
 Long-term endurance training may attenuate low-grade inflammation in the elderly  
 Exercise may be beneficial in reducing FLCs in inflammatory and autoimmune 
disease  
